CN Patent

CN101023090B — Hiv蛋白酶抑制剂的前药

Assigned to AbbVie Inc · Expires 2013-03-27 · 13y expired

What this patent protects

本发明公开了作为HIV蛋白酶抑制剂的前药的下式的化合物。本发明还公开了用于抑制HIV蛋白酶活性和治疗HIV感染的方法和组合物。

USPTO Abstract

本发明公开了作为HIV蛋白酶抑制剂的前药的下式的化合物。本发明还公开了用于抑制HIV蛋白酶活性和治疗HIV感染的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101023090B
Jurisdiction
CN
Classification
—
Expires
2013-03-27
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.